Page 13 - Sight Sciences Inc News Today

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Sight Sciences to similar companies based on the strength of its earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and risk. Valuation and […]

Investment Analysts’ upgrades for Tuesday, May 31st: Amundi (OTCMKTS:AMDUF) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. Aperam (OTCMKTS:APEMY) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. China Gas (OTCMKTS:CGHLY) was upgraded by analysts at Daiwa Capital […]

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it compare to its peers? We will compare Sight Sciences to similar companies based on the strength of its institutional ownership, risk, dividends, analyst recommendations, valuation, profitability and earnings. Insider & Institutional Ownership […]

Nuvectra (OTCMKTS:NVTRQ – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings and […]

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its peers? We will compare Sight Sciences to similar companies based on the strength of its institutional ownership, valuation, profitability, risk, dividends, analyst recommendations and earnings. Insider and Institutional Ownership […]

SGHT earnings call for the period ending March 31, 2022.

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $11.67, but opened at $11.93. Sight Sciences shares last traded at $11.68, with a volume of 6,993 shares trading hands. A number of equities research analysts have commented on the company. Citigroup […]

Nemaura Medical (NASDAQ:NMRD – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Analyst Recommendations This is a breakdown of current ratings […]

Sight Sciences (NASDAQ:SGHT – Get Rating) announced its earnings results on Thursday. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.39) by $0.05, Fidelity Earnings reports. Sight Sciences updated its FY 2022 guidance to EPS. Shares of SGHT opened at $13.46 on Friday. The company has a debt-to-equity […]